MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.32
+0.17 (0.94%)
At close: Mar 9, 2026, 4:00 PM EDT
18.29
-0.03 (-0.16%)
After-hours: Mar 9, 2026, 7:37 PM EDT
MLTX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 334.52 | 180.43 | 451.17 | 39.51 | 8.04 |
| Short-Term Investments | 59.45 | 267.6 | 59.84 | 32.61 | - |
| Cash & Short-Term Investments | 393.97 | 448.03 | 511.01 | 72.11 | 8.04 |
| Cash Growth | -12.07% | -12.32% | 608.60% | 797.08% | - |
| Other Receivables | 4.87 | 2.84 | 1.06 | 0.22 | 0.15 |
| Receivables | 4.87 | 2.84 | 1.06 | 0.22 | 0.15 |
| Prepaid Expenses | 22.86 | 23.42 | 2.1 | 4.18 | 1.45 |
| Total Current Assets | 421.69 | 474.29 | 514.17 | 76.51 | 9.64 |
| Property, Plant & Equipment | 2.14 | 3.64 | 3.95 | 0.33 | 0.05 |
| Long-Term Deferred Charges | 0.6 | - | - | - | - |
| Other Long-Term Assets | - | - | 8.42 | - | - |
| Total Assets | 424.43 | 477.93 | 526.54 | 76.84 | 9.68 |
| Accounts Payable | 0.37 | 0.18 | 0.33 | 0.16 | 0.03 |
| Accrued Expenses | 42.79 | 20.27 | 8.07 | 7.24 | 4.76 |
| Short-Term Debt | - | - | - | - | 15 |
| Current Portion of Leases | 1.23 | 1.37 | 1.2 | 0.15 | - |
| Current Income Taxes Payable | 1.09 | 0.64 | 0.37 | 0.11 | 0.06 |
| Other Current Liabilities | - | - | - | - | 1.23 |
| Total Current Liabilities | 45.48 | 22.46 | 9.97 | 7.67 | 21.09 |
| Long-Term Debt | 74.1 | - | - | - | - |
| Long-Term Leases | 0.37 | 1.46 | 2.5 | 0.13 | - |
| Pension & Post-Retirement Benefits | - | 0.62 | 0.58 | 0.28 | 0.24 |
| Total Liabilities | 119.95 | 24.54 | 13.05 | 8.08 | 21.33 |
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 |
| Additional Paid-In Capital | 766.78 | 677.42 | 609.97 | 129.19 | 42.06 |
| Retained Earnings | -462.91 | -235.59 | -116.66 | -80.65 | -53.64 |
| Treasury Stock | - | - | - | - | -0.01 |
| Comprehensive Income & Other | 0.6 | 5 | 2.36 | 0.35 | -0.17 |
| Total Common Equity | 304.48 | 446.83 | 495.68 | 48.9 | -11.72 |
| Minority Interest | - | 6.57 | 17.82 | 19.87 | - |
| Shareholders' Equity | 304.48 | 453.39 | 513.49 | 68.77 | -11.65 |
| Total Liabilities & Equity | 424.43 | 477.93 | 526.54 | 76.84 | 9.68 |
| Total Debt | 75.71 | 2.83 | 3.7 | 0.28 | 15 |
| Net Cash (Debt) | 318.26 | 445.2 | 507.31 | 71.83 | -6.96 |
| Net Cash Growth | -28.51% | -12.24% | 606.24% | - | - |
| Net Cash Per Share | 4.94 | 7.08 | 10.33 | 2.45 | -0.89 |
| Filing Date Shares Outstanding | 71.73 | 63.28 | 62.87 | 39.15 | 0.3 |
| Total Common Shares Outstanding | 71.37 | 63.08 | 60.47 | 38.98 | 0.3 |
| Working Capital | 376.22 | 451.83 | 504.2 | 68.85 | -11.45 |
| Book Value Per Share | 4.27 | 7.08 | 8.20 | 1.25 | -38.57 |
| Tangible Book Value | 304.48 | 446.83 | 495.68 | 48.9 | -11.72 |
| Tangible Book Value Per Share | 4.27 | 7.08 | 8.20 | 1.25 | -38.57 |
Source: S&P Capital IQ. Standard template. Financial Sources.